Prospective Evaluation of Drug-Eluting Stents in Routine Clinical Practice (ASAN PCI Registry)
Recruiting now
Conditions studied: Coronary Artery Disease
In brief
The objective of this study is to evaluate effectiveness and safety of drug-eluting stent implantation in the "real world" daily practice.
Key facts
- Study ID
- NCT01788592
- Run by
- Seung-Jung Park
- People needed
- 50000
- Starts
- 2003-01-01
- Expected to finish
- 2030-10-01
- Last updated by the study team
- 2026-01-02
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- coronary disease amenable to percutaneous coronary intervention (PCI)
- no clinical and lesion limitations
You may not qualify if…
- patients with a mixture of several drug eluting stents
- terminal illness with life expectancy less than 1 year
- patients with cardiogenic shock
Where it is running
- Asan Medical Center — Seoul, South Korea (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.